Abcl stock forecast.

According to 14 stock analysts, the average 12-month stock price forecast for Palantir stock is $13.25, which predicts a decrease of -34.63%. The lowest target is $5.00 and the highest is $25. On average, analysts rate Palantir stock as a hold.Complete AbCellera Biologics Inc. stock information by Barron's. View real-time ABCL stock price and news, along with industry-best analysis.Bionano Genomics Inc () Stock Market info Recommendations: Buy or sell Bionano Genomics stock? Wall Street Stock Market & Finance report, prediction for the future: You'll find the Bionano Genomics share forecasts, stock quote and buy / sell signals below.According to present data Bionano Genomics's BNGO shares and potentially its …Price Performance Review of ABCL. On Monday, AbCellera Biologics Inc [NASDAQ:ABCL] saw its stock fall -4.79% to $4.47. On the same session, the stock had its day’s lowest price of $4.44, but rose to a high of $4.78. Over the last five days, the stock has gained 10.77%. AbCellera Biologics Inc shares have fallen nearly -55.82% since the year ...Bitfarms Ltd () Stock Market info Recommendations: Buy or sell Bitfarms stock? Wall Street Stock Market & Finance report, prediction for the future: You'll find the Bitfarms share forecasts, stock quote and buy / sell signals below.According to present data Bitfarms's BITF shares and potentially its market environment have been in a bullish cycle in the …

Nov 25, 2023 · At the close of trading, the stock’s price was $4.50, to imply an increase of 1.58% or $0.07 in intraday trading. The ABCL share’s 52-week high remains $14.15, putting it -214.44% down since that peak but still an impressive 14.0% since price per share fell to its 52-week low of $3.87. TipRanks | Stock Market Research, News and Analyst Forecasts - TipRanks.comNov 21, 2023 · According to analyst projections, ABCL’s forecast low is $10.00 with $34.00 as the target high. To hit the forecast high, the stock’s price needs a -639.13% plunge from its current level, while the stock would need to soar -117.39% for it to hit the projected low. AbCellera Biologics Inc (ABCL) estimates and forecasts

May 4, 2023 at 2:15 PM · 3 min read. AbCellera Biologics Inc. (ABCL) came out with a quarterly loss of $0.14 per share versus the Zacks Consensus Estimate of a loss of $0.12. This compares to ...

Find the latest Standard Lithium Ltd. (SLI) stock quote, history, news and other vital information to help you with your stock trading and investing.1 Month Ago. -$0.12. 3 Months Ago. -$0.14. AbCellera Biologics Inc. analyst estimates, including ABCL earnings per share estimates and analyst recommendations.2 days ago · Stock Price Forecast. According to 7 stock analysts, the average 12-month stock price forecast for ABCL stock stock is $23.29, which predicts an increase of 436.64%. The lowest target is $12 and the highest is $32. On average, analysts rate ABCL stock stock as a strong buy. As a result, it might be a surprise to see that the analysts have cut their price target 10% to US$30.00, which could suggest the forecast improvement in performance is not expected to last.4 ago 2023 ... As of Friday, August 04, AbCellera Biologics Inc's ABCL share price has dipped by 13.34%, which has investors questioning if this is right ...

AbCellera Biologics Inc stock price forecast for further price development down to -37.16% (time horizon: 1 day) and price target of 4.13 USD. Short-term (time horizon: 2 weeks) AbCellera Biologics Inc share price prediction for 2024-01-05 with daily closed price projections

All quotes are in local exchange time. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Intraday data delayed at least 15 minutes or per exchange ...

15 sept 2023 ... My next multi bagger stock is Abcellera Biologics - stock symbol: ABCL. Victor H Investing•528 views · 12:08 · Go to channel · Community is ...According to our current ABCL stock forecast, the value of AbCellera Biologics shares will drop by -6.13% and reach $ 4.40 per share by December 6, 2023. …AbCellera Biologics Inc. research and ratings by Barron's. View ABCL revenue estimates and earnings estimates, as well as in-depth analyst breakdowns.Per our algorithmic AbCellera Biologics stock forecast, ABCL’s price could see a decrease of -13.49% over the next five days and reach $ 4.14 on Dec 05, 2023. In the next month, AbCellera Biologics stock is forecasted to lose -1.11% and hit $ …Find the latest ABVC BioPharma, Inc. (ABVC) stock quote, history, news and other vital information to help you with your stock trading and investing.About the AbCellera Biologics Inc stock forecast. As of 2023 November 28, Tuesday current price of ABCL stock is 4.530$ and our data indicates that the asset price has been in a downtrend for the past 1 year (or since its inception).We don't have any Insights for this stock currently. Aditya Birla Cap. Share Price Returns. 1 Day, 1.67%. 1 Month ...

James O'Neil/DigitalVision via Getty Images. AbCellera Biologics ( NASDAQ: ABCL) to date has been quite a lousy investment. From the IPO high of $58.90, all the way down to the current price of ...AbCellera ( NASDAQ: ABCL) listed on the Nasdaq in December 2020, completing a monstrous initial public offering of 24.15m shares at a price of $20 per share, for funds of ~$483m, which would be ...Complete AbCellera Biologics Inc. stock information by Barron's. View real-time ABCL stock price and news, along with industry-best analysis.Nov 25, 2023 · At the close of trading, the stock’s price was $4.50, to imply an increase of 1.58% or $0.07 in intraday trading. The ABCL share’s 52-week high remains $14.15, putting it -214.44% down since that peak but still an impressive 14.0% since price per share fell to its 52-week low of $3.87. ALK Stock 12 Months Forecast. $51.25. (62.03% Upside) Based on 12 Wall Street analysts offering 12 month price targets for Alaska Air in the last 3 months. The average price target is $51.25 with a high forecast of $70.00 and a low forecast of $41.00. The average price target represents a 62.03% change from the last price of $31.63.Oct 13, 2023 · According to data from CNN Money, the 8 analysts offering 12-month price forecasts for ABCL had a median target of $24.50, with a high estimate of $34.00 and a low estimate of $12.00. This median estimate represents a remarkable increase of +517.13% from the stock’s last price of $3.97. ABCL's price/sales ratio is 23.26; that's higher than the P/S ratio of 95.29% of US stocks. Revenue growth over the past 12 months for ABCELLERA BIOLOGICS INC comes in at -91.65%, a number that bests just 1.31% of the US stocks we're tracking. Stocks that are quantitatively similar to ABCL, based on their financial statements, market ...

AbCellera Biologics Inc (ABCL). 4.34 -0.26 (-5.65%) USD ... Price to book value is a valuation ratio that is measured by stock price / book value per share.

Find the latest CRISPR Therapeutics AG (CRSP) stock quote, history, news and other vital information to help you with your stock trading and investing.ABCL stock's Price/Earning ratio is 12.33. Our analysis grades ABCL stock's Price / Earning ratio at F. This means that ABCL stock's Price/Earning ratio is above 62% of the stocks in the Biotechnology sector in the NSD exchange. Based on this ABCL may be a overvalued for its sector.AbCellera Biologics Inc stock price forecast for further price development down to -37.16% (time horizon: 1 day) and price target of 4.13 USD. Short-term (time horizon: 2 weeks) AbCellera Biologics Inc share price prediction for 2024-01-05 with daily closed price projectionsNov 21, 2023 · According to analyst projections, ABCL’s forecast low is $10.00 with $34.00 as the target high. To hit the forecast high, the stock’s price needs a -639.13% plunge from its current level, while the stock would need to soar -117.39% for it to hit the projected low. AbCellera Biologics Inc (ABCL) estimates and forecasts It's typically categorized as a valuation metric and is most often quoted as Cash Flow per Share and as a Price to Cash flow ratio. In this case, it's the cash flow growth that's being looked at ...Stock Price Forecast. The 8 analysts offering 12-month price forecasts for Abcellera Biologics Inc have a median target of 20.50, with a high estimate of 34.00 and a low estimate of 10.00. The median estimate represents a +323.99% increase from the …

ABCL CA00288U1066 ... Analysts covering this company mostly recommend stock overweighting or purchase. ... This change in forecast points out a decline in activity as well as pessimistic analyses of …

Previous Close $4.4. Volume 1.91M. Average Volume (3M) 1.64M. Market Cap. $1.28B. Enterprise Value $1.28B. Total Cash (Recent Filing) $795.69K. Total Debt (Recent Filing) $84.03K. Price to Earnings (P/E) -9.8.

PLTR Stock 12 Months Forecast. Based on 15 Wall Street analysts offering 12 month price targets for Palantir Technologies in the last 3 months. The average price target is $14.67 with a high forecast of $25.00 and a low forecast of $5.00. The average price target represents a -23.59% change from the last price of $19.20.According to . 3 Wall Street analysts that have issued a 1 year ABCL price target, the average ABCL price target is $18.67, with the highest ABCL stock price forecast at $24.00 and the lowest ABCL stock price forecast at $12.00. AbCellera's Q2 2023 financials reveal declining revenues and high R&D expenses, leading to caution in investment decision. Learn why I rate ABCL stock a hold.Complete AbCellera Biologics Inc. stock information by Barron's. View real-time ABCL stock price and news, along with industry-best analysis. Planning a trip can be an exciting but challenging task. From booking accommodations to creating an itinerary, there are countless details to consider. One crucial aspect that should never be overlooked is checking the 7-day weather forecas...This is based on 4 Wall Streets Analysts 12-month price targets, issued in the past 3 months. The highest analyst price target is $20.00 ,the lowest forecast is $10.00. The …The 8 analysts offering 1 year price forecasts for ABCL have a max estimate of — and a min estimate of —. Analyst rating Based on 9 analysts giving stock ratings to ABCL in the past 3 months.Analyst projections state that ABCL is forecast to be at a low of $10.00 and a high of $34.00. In order for the stock price to hit the forecast high, the stock would need to plunge -660.63% from its current level, while the stock would need to crash -123.71% from its current level to reach the projected low.ABCL's price/sales ratio is 23.26; that's higher than the P/S ratio of 95.29% of US stocks. Revenue growth over the past 12 months for ABCELLERA BIOLOGICS INC comes in at -91.65%, a number that bests just 1.31% of the US stocks we're tracking. Stocks that are quantitatively similar to ABCL, based on their financial statements, market ...Inflation hits lowest level since 2021, Fed's preferred gauge shows. Find the latest AbCellera Biologics Inc. (ABCL) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight ... https://www.abcellera.com. AbCellera Biologics Inc. builds an engine for antibody drug discovery and development. Its engine discovers antibodies from natural immune responses, which are pre-enriched for antibodies. The company had discovery programs that are either completed, in progress, or under contract with partners.Apple Inc. Common Stock. $191.45 +1.76 +0.93%. Find the latest dividend history for AbCellera Biologics Inc. Common Shares (ABCL) at Nasdaq.com.

Track AbCellera Biologics Inc (ABCL) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsAnalyst projections state that ABCL is forecast to be at a low of $10.00 and a high of $34.00. In order for the stock price to hit the forecast high, the stock would need to plunge -618.82% from its current level, while the stock would need to crash -111.42% from its current level to reach the projected low.AbCellera Biologics Inc. (ABCL) came out with a quarterly loss of $0.10 per share versus the Zacks Consensus Estimate of $0.01. This compares to earnings of $0.19 per share a year ago. These ...ABCL Quick Quote. ABCL - Free Report) came out with a quarterly loss of $0.11 per share versus the Zacks Consensus Estimate of a loss of $0.13. This compares to loss of $0.02 per share a year ago ...Instagram:https://instagram. best mortgage lenders in dallashow to trade energy futuresbest free stock chartsnowflake forecast Jul 12, 2023 · Find the latest AbCellera (NASDAQ: ABCL) stock information. Given its relevancies, ABCL stock gained 13% of equity value in the trailing year. Still, ABCL surprisingly ranks among the most undervalued biotech stocks to buy. Currently, the market prices ... celgene otezlabest stocks to day trade today ABCL - Cup & Handle Breakout Trade Abcellera Biologics is a biotech stock setting up in a textbook cup with handle pattern. The stock has growing institutional sponsorship as shown in the chart from MarketSmith on the chart. It also has a relative strength ranking of 97/100. Shares formed a cup with a 37% depth and have since driftAbcellera ...Find the latest Institutional Holdings data for AbCellera Biologics Inc. Common Shares (ABCL) at Nasdaq.com. microsoft dividend yield We’ve all flipped between different weather apps, wondering why each is giving a slightly different report. Before we look at AccuWeather, it’s important to understand the basics of weather forecasting. In the past, weather predictions were...ABCL CA00288U1066 ... Analysts covering this company mostly recommend stock overweighting or purchase. ... This change in forecast points out a decline in activity as well as pessimistic analyses of …Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools. Identify stocks that meet your criteria using seven unique stock screeners.